Atlas Trials

Role of Day +60 WT1 Assessment on Bone Marrow in Predicting Relapse and Mortality After Allogeneic Stem Cell Transplantation

Clinical trial NCT05755633 · COMPLETED

Trial details

NCT number
NCT05755633
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status
COMPLETED
Study type
OBSERVATIONAL
Assessment of the WT1 Expression Level on Bone Marrow Samples Collected at Day +60 After Allogeneic Stem
Start date
2021-04-22
Primary completion
2021-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.